Reversible Leukoencephalopathy After Oral Methotrexate: Figure 1.
Authors:
- Hille KoppenHKHille Koppen
- Judith A. WesselsJWJudith A. Wessels
- Jaques A.P.M. EwalsJEJaques A.P.M. Ewals
- Frank E.E. TreurnietFTFrank E.E. Treurniet
Open Access
- 1 September 2012
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 39 (9) , 1906-1907
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Reversible Leukoencephalopathy After Oral Methotrexate: Figure 1.The Journal of Rheumatology, 2012
- Methotrexate-induced myelopathy responsive to substitution of multiple folate metabolitesJournal of Neuro-Oncology, 2009
- Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphomaNeuro-Oncology, 2009
- Reduced folate carrier polymorphism determines methotrexate uptake by B cells and CD4+ T cellsRheumatology, 2007
- Massive myelinolytic leukoencephalopathy in a patient medicated with low-dose oral methotrexate for rheumatoid arthritis: an autopsy reportActa Neuropathologica, 2007
- Disseminated necrotizing leukoencephalopathy following low‐dose oral methotrexateEuropean Journal of Neurology, 2007
- Predicting long-term seizure outcome after resective epilepsy surgeryNeurology, 2005
- MTX-induced white matter changes are associated with polymorphisms of methionine metabolismNeurology, 2005
- Cerebellar volume and long-term use of phenytoinSeizure: European Journal of Epilepsy, 2003
- The Effect of Chronic Phenytoin Treatment on Tissue Folate Concentrations and on the Activities of the Methyl Synthetic Enzymes in the RatThe Journal of Nutrition, 1983